111, Inc.
111, Inc. YI Peers
See (YI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| YI | $7.89 | +3.68% | 68.39M | -7.51 | -$1.05 | N/A |
| INSM | $67.22 | +2.45% | 12.24B | -11.34 | -$5.93 | N/A |
| WBA | $11.18 | +0.45% | 9.67B | -1.67 | -$6.69 | +6.70% |
| ONC | $225.77 | +2.65% | 1.72B | -62.20 | -$3.63 | N/A |
| LFMDP | $24.34 | -0.65% | 1.11B | -10.79 | -$2.26 | N/A |
| HROWM | $26.70 | +0.56% | 979.88M | N/A | N/A | +11.15% |
| HROWL | $25.20 | -0.40% | 924.83M | N/A | N/A | N/A |
| LFMD | $9.67 | +1.15% | 439.48M | -29.30 | -$0.33 | N/A |
| HITI | $2.31 | -1.70% | 186.97M | -38.50 | -$0.06 | N/A |
| PETS | $3.76 | -0.53% | 77.67M | 376.00 | $0.01 | N/A |
Stock Comparison
YI vs INSM Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, INSM has a market cap of 12.24B. Regarding current trading prices, YI is priced at $7.89, while INSM trades at $67.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas INSM's P/E ratio is -11.34. In terms of profitability, YI's ROE is +0.10%, compared to INSM's ROE of -4.47%. Regarding short-term risk, YI is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs WBA Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, WBA has a market cap of 9.67B. Regarding current trading prices, YI is priced at $7.89, while WBA trades at $11.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas WBA's P/E ratio is -1.67. In terms of profitability, YI's ROE is +0.10%, compared to WBA's ROE of -0.55%. Regarding short-term risk, YI is more volatile compared to WBA. This indicates potentially higher risk in terms of short-term price fluctuations for YI.
YI vs ONC Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, ONC has a market cap of 1.72B. Regarding current trading prices, YI is priced at $7.89, while ONC trades at $225.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas ONC's P/E ratio is -62.20. In terms of profitability, YI's ROE is +0.10%, compared to ONC's ROE of -0.19%. Regarding short-term risk, YI and ONC have similar daily volatility (2.56).
YI vs LFMDP Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, LFMDP has a market cap of 1.11B. Regarding current trading prices, YI is priced at $7.89, while LFMDP trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas LFMDP's P/E ratio is -10.79. In terms of profitability, YI's ROE is +0.10%, compared to LFMDP's ROE of +2.33%. Regarding short-term risk, YI is more volatile compared to LFMDP. This indicates potentially higher risk in terms of short-term price fluctuations for YI.
YI vs HROWM Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, HROWM has a market cap of 979.88M. Regarding current trading prices, YI is priced at $7.89, while HROWM trades at $26.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas HROWM's P/E ratio is N/A. In terms of profitability, YI's ROE is +0.10%, compared to HROWM's ROE of -0.28%. Regarding short-term risk, YI is more volatile compared to HROWM. This indicates potentially higher risk in terms of short-term price fluctuations for YI.
YI vs HROWL Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, HROWL has a market cap of 924.83M. Regarding current trading prices, YI is priced at $7.89, while HROWL trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas HROWL's P/E ratio is N/A. In terms of profitability, YI's ROE is +0.10%, compared to HROWL's ROE of -0.36%. Regarding short-term risk, YI is more volatile compared to HROWL. This indicates potentially higher risk in terms of short-term price fluctuations for YI.
YI vs LFMD Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, LFMD has a market cap of 439.48M. Regarding current trading prices, YI is priced at $7.89, while LFMD trades at $9.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas LFMD's P/E ratio is -29.30. In terms of profitability, YI's ROE is +0.10%, compared to LFMD's ROE of +2.33%. Regarding short-term risk, YI is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs HITI Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, HITI has a market cap of 186.97M. Regarding current trading prices, YI is priced at $7.89, while HITI trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas HITI's P/E ratio is -38.50. In terms of profitability, YI's ROE is +0.10%, compared to HITI's ROE of -0.05%. Regarding short-term risk, YI is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs PETS Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, PETS has a market cap of 77.67M. Regarding current trading prices, YI is priced at $7.89, while PETS trades at $3.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas PETS's P/E ratio is 376.00. In terms of profitability, YI's ROE is +0.10%, compared to PETS's ROE of +0.00%. Regarding short-term risk, YI is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs RNTX Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, RNTX has a market cap of 51.90M. Regarding current trading prices, YI is priced at $7.89, while RNTX trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas RNTX's P/E ratio is -0.67. In terms of profitability, YI's ROE is +0.10%, compared to RNTX's ROE of -0.80%. Regarding short-term risk, YI is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs RAD Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, RAD has a market cap of 36.76M. Regarding current trading prices, YI is priced at $7.89, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas RAD's P/E ratio is -0.05. In terms of profitability, YI's ROE is +0.10%, compared to RAD's ROE of +0.91%. Regarding short-term risk, YI is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs MEDS Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, MEDS has a market cap of 13.28M. Regarding current trading prices, YI is priced at $7.89, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas MEDS's P/E ratio is -0.31. In terms of profitability, YI's ROE is +0.10%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, YI is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs CJJD Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, CJJD has a market cap of 9.95M. Regarding current trading prices, YI is priced at $7.89, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas CJJD's P/E ratio is -0.46. In terms of profitability, YI's ROE is +0.10%, compared to CJJD's ROE of -0.30%. Regarding short-term risk, YI is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs NEUP Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, NEUP has a market cap of 8.33M. Regarding current trading prices, YI is priced at $7.89, while NEUP trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas NEUP's P/E ratio is 0.43. In terms of profitability, YI's ROE is +0.10%, compared to NEUP's ROE of -0.43%. Regarding short-term risk, YI is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs ATNFW Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, ATNFW has a market cap of 6.40M. Regarding current trading prices, YI is priced at $7.89, while ATNFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas ATNFW's P/E ratio is N/A. In terms of profitability, YI's ROE is +0.10%, compared to ATNFW's ROE of -2.12%. Regarding short-term risk, YI is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs SSY Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, SSY has a market cap of 6.05M. Regarding current trading prices, YI is priced at $7.89, while SSY trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas SSY's P/E ratio is -2.05. In terms of profitability, YI's ROE is +0.10%, compared to SSY's ROE of +0.12%. Regarding short-term risk, YI is more volatile compared to SSY. This indicates potentially higher risk in terms of short-term price fluctuations for YI.
YI vs MDVL Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, MDVL has a market cap of 2.91M. Regarding current trading prices, YI is priced at $7.89, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas MDVL's P/E ratio is -0.05. In terms of profitability, YI's ROE is +0.10%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, YI is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs LFLYW Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, LFLYW has a market cap of 907262.00. Regarding current trading prices, YI is priced at $7.89, while LFLYW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas LFLYW's P/E ratio is -0.06. In terms of profitability, YI's ROE is +0.10%, compared to LFLYW's ROE of +0.39%. Regarding short-term risk, YI is more volatile compared to LFLYW. This indicates potentially higher risk in terms of short-term price fluctuations for YI.
YI vs LFLY Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, LFLY has a market cap of 722681.00. Regarding current trading prices, YI is priced at $7.89, while LFLY trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas LFLY's P/E ratio is -0.10. In terms of profitability, YI's ROE is +0.10%, compared to LFLY's ROE of +0.39%. Regarding short-term risk, YI is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for YI.
YI vs BIMI Comparison
YI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 68.39M. In comparison, BIMI has a market cap of 9423.00. Regarding current trading prices, YI is priced at $7.89, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -7.51, whereas BIMI's P/E ratio is N/A. In terms of profitability, YI's ROE is +0.10%, compared to BIMI's ROE of -2.93%. Regarding short-term risk, YI is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for YI.